SPC365

Cardiac Rehabilitation Phase 3 - Who are they?

Session: SESSÃO DE POSTERS 03 - REABILITAÇÃO CARDÍACA AO LONGO DO CONTINUUM DE CUIDADOS - DA PREVENÇÃO AOS RESULTADOS A LONGO PRAZO
Speaker: Rodrigo Malveiro Afonso

Congress: CPC 2025
Topic: J. Preventive Cardiology
Theme: 29. Rehabilitation and Sports Cardiology
Subtheme: 29.2 Cardiovascular Rehabilitation
Session Type: Cartazes
FP Number: ---
Authors: Rodrigo Afonso; Miguel Azaredo Raposo; Catarina Gregório; Madalena Lemos Pires; Mariana Borges; Gonçalo Sá; Pedro Alves da Silva; Nelson Cunha; Inês Aguiar-Ricardo; Fausto J. Pinto; Rita Pinto; Ana Abreu

<p><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><strong><span style="font-family:&quot;Calibri&quot;,sans-serif">Introduction:&nbsp;</span></strong></span></span><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="font-family:&quot;Calibri&quot;,sans-serif">Cardiac Rehabilitation (CR) Phase 3 acts as an extension to Phase 2, encompassing a very heterogeneous patient population with structured exercise, nutrition counselling and educational sessions and an already established benefit in health outcomes among patients with cardiovascular diseases.</span></span></span></p>

<p>&nbsp;</p>

<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><strong><span style="font-family:&quot;Calibri&quot;,sans-serif">Purpose:&nbsp;</span></strong></span></span><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="font-family:&quot;Calibri&quot;,sans-serif">To characterize the patient population enrolled in a structured phase 3 CR program.</span></span></span></p>

<p style="text-align:justify">&nbsp;</p>

<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><strong><span style="font-family:&quot;Calibri&quot;,sans-serif">Methods:&nbsp;</span></strong></span></span><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="font-family:&quot;Calibri&quot;,sans-serif">Single centre prospective cohort study of patients enrolled in a phase 3 CR program between 2016 and 2024. We analysed the demographic and social characteristics, risk factors, clinical indications for referral and baseline echocardiogram data. A composite outcome of all-cause deaths, cardiovascular (CV) hospitalizations and urgent visits was analysed.</span></span></span></p>

<p style="text-align:justify">&nbsp;</p>

<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><strong><span style="font-family:&quot;Calibri&quot;,sans-serif">Results:&nbsp; </span></strong><span style="font-family:&quot;Calibri&quot;,sans-serif">We included 284 patients, 78% male, 61&plusmn;11 years. Mean follow-up time was 3.4&plusmn;2.4 years. Concerning social and demographic characteristics: 69% of patients were married, 47% were employed in a full-time job and 39% were already retired. Only 4% were unemployed. At least 60% of our patients had attended college, of which 32% had at least a master&#39;s degree. The majority of patients lived nearby the phase 3 CR facility with up to 62% of patients reporting a travel duration from their home to the facility inferior to 30 minutes. Most of the patients (53%)reported previous physical activity experience from recreational to competitive sports. About 67% of our population transitioned from phase 2. The number of sessions per week varied from 2 to 3, with 82% of patients participating in phase 3 activities 3 times per week. At the time of data collection, we reported high levels of adherence to the program with 64% of the total patients enrolled still being active in phase 3 CR activities. The two main reasons for dropout were:&nbsp; incompatibility with work schedule (8%); change in health status (7%) and the covid-19 pandemic (7%). Regarding risk factors, 18% of patients had diabetes, 9% were active smokers, 50% had hypertension, 46% had dyslipidemia, 7% had atrial fibrillation, 5% had a history of stroke. The main clinical indication for referral was ischemic cardiomyopathy (84% of patients). Echocardiogram data were as followed: Left ventricular ejection fraction (54&plusmn;13%) and TAPSE (21&plusmn;5mm). Finally, there were a total of 4 deaths, 13 hospitalizations due to CV causes and 34 urgent visits to the emergency department due to CV causes throughout follow-up. The mean time to a first composite event was 2.7 &plusmn;1.8 years.</span></span></span></p>

<p style="text-align:justify">&nbsp;</p>

<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><strong><span style="font-family:&quot;Calibri&quot;,sans-serif">Conclusions: </span></strong><span style="font-family:&quot;Calibri&quot;,sans-serif">Our data encompasses a wide range of patient population characteristics enrolled in a phase 3 CR program. Characterizing this population is crucial for tailoring interventions, enhancing adherence, and optimizing outcomes. Personalized approaches and strict risk factor control remain essential to minimize adverse events and promote sustained cardiovascular health.</span></span></span></p>

<p style="text-align:justify">&nbsp;</p>